Analysis of Work Accident Risks in Scaffolding Work Using the FMEA Method (Case Study: Massuetera Engineering Offshore Project

Adi Muslim Kamil; Olvi Pamadya Utaya Kusuma; Monica Dewi; Susilowati

doi:10.55227/ijhet.v4i4.443

Authors

Adi Muslim Kamil Universitas Kahuripan Kediri, Indonesia
Olvi Pamadya Utaya Kusuma Universitas Kahuripan Kediri, Indonesia
Monica Dewi Universitas Kahuripan Kediri, Indonesia
Susilowati Universitas Kahuripan Kediri, Indonesia

DOI:

https://doi.org/10.55227/ijhet.v4i4.443

Keywords:

Occupational Safety, Offshore Project, Scaffolding, Risk Analysis, FMEA, Work Accident Prevention

Abstract

This study analyzes occupational accident risks in scaffolding activities on offshore construction projects using the Failure Mode and Effect Analysis (FMEA) method. The research was conducted at the Massuetera Engineering offshore project with a quantitative descriptive approach involving 18 respondents consisting of scaffolders and supervisors. Data were collected using a structured questionnaire with 63 items covering three main FMEA parameters—Severity, Occurrence, and Detection—and analyzed to calculate the Risk Priority Number (RPN). The findings identified 23 potential hazards in scaffolding installation and dismantling activities. The three dominant high-risk factors were: (1) slipping or being struck by materials during mobilization (RPN = 182.44), (2) falling or instability during vertical pole installation (RPN = 176.38), and (3) falling from the platform edge during guardrail installation (RPN = 174.88). These risks highlight that height and structural stability remain the most critical safety challenges in offshore scaffolding work. The study emphasizes the need for systematic risk mitigation through enhanced worker training, strict safety procedures, proper use of personal protective equipment (PPE), and continuous monitoring. The results contribute to improving the Occupational Safety and Health (OSH) management system for offshore construction projects by providing a measurable framework for proactive hazard prevention based on FMEA analysis.

Downloads

Download data is not yet available.

References

Adeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A., & Rudan, I. (2022). Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modeling analysis. The Lancet Respiratory Medicine, 10(5), 447–458.https://doi.org/10.1016/S2213-2600(21)00407-0

Akbar, Y., Mursal, M., & Amni, R. (2022). Anxiety levels of COPD sufferers are stable in Indonesia. Islamic Nursing Scientific Journal, 7(1), 28–33.https://doi.org/10.24252/jiki.v7i1.29413

Aprilen, D., Sari, NP, & Sari, DP (2022). The relationship between age and the degree of chronic obstructive pulmonary disease. Indonesian Respiration Journal, 42(2), 123–130.https://doi.org/10.36497/jri.v42i2.805

Buttery, S.C., Zysman, M., Vikjord, S.A.A., Hopkinson, N.S., Jenkins, C., & Vanfleteren, LEGW (2021). Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity. Respirology, 26(5), 419–441.https://doi.org/10.1111/resp.14041

Carlson, S. A. (2022). Geographic differences in sex-specific chronic obstructive pulmonary disease mortality rate trends among adults aged ≥25 years—United States, 1999–2019. MMWR Morbidity and Mortality Weekly Report, 71, 1–7.https://doi.org/10.15585/mmwr.mm7146a1

Creswell, J. W., & Creswell, J. D. (2021). Research design: Qualitative, quantitative, and mixed methods approaches (5th ed.). SAGE Publications.https://doi.org/10.4135/9781071802824

Cherepii, N.V. (2017). Identification and assessment of the chronic obstructive pulmonary disease risk factors in first diagnosed patients. Bukovinian Medical Herald, 21(2), 121–126.https://doi.org/10.24061/2413-0737.XXI.2.82.2017.24

Ekaputri, RA, Sari, DP, & Sari, NP (2023). Risk factors of death in chronic obstructive pulmonary disease patients. JUXTA, 14(1), 1–8.https://doi.org/10.20473/juxta.v14i1.42038

Fazekas-Pongor, V., Fekete, M., Balazs, P., Árva, D., Pénzes, M., & Tarantini, S. (2021). Health-related quality of life of COPD patients aged over 40 years. Physiological International, 108(2), 261–273.https://doi.org/10.1556/2060.2021.00022

Gogou, E., Hatzoglou, C., Zarogiannis, S.G., Siachpazidou, D., Gerogianni, I., & Kotsiou, O.S. (2022). Are younger COPD patients vaccinated for influenza and pneumococcus? Respiratory Medicine, 203, 106988.https://doi.org/10.1016/j.rmed.2022.106988

Han, M. K., Ye, W., Wang, D., White, E., Arjomandi, M., & Barjaktarevic, I. (2022). Bronchodilators in symptomatic tobacco-exposed persons with preserved spirometry for the RETHINC Study Group. European Respiratory Journal, 60(Suppl 66), 1–10.https://doi.org/10.1183/13993003.congress-2022.266

Jannah, M., Sari, DP, & Sari, NP (2025). Factors that affected the mortality rate of chronic obstructive pulmonary disease patients. Indonesian Respiration Journal, 45(1), 1–10.https://doi.org/10.36497/jri.v45i1.805

Kang, J., Lee, J.S., Lee, S.W., Lee, J.B., & Oh, Y.M. (2021). Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: A patient-level pooled analysis of phase-3 randomized clinical trials. Respiratory Research, 22(1), 1–11.https://doi.org/10.1186/s12931-021-01713-2

Lindberg, A., Szakacs, E., Stridsman, C., Sawalha, S., Nilsson, U., & Hedman, L. (2022). Among both men and women with COPD ever-smokers have a higher disease burden and worse prognosis than never-smokers. European Respiratory Journal, 60(Suppl 66), 1–10.https://doi.org/10.1183/13993003.congress-2022.266

Marfiani, E., Ichwani, J., Widajanti, N., Maranatha, D., & Amin, M. (2020). Relationship between level of serum adiponectin and frailty in elderly patients with chronic obstructive pulmonary disease. Indonesian Journal of Tropical and Infectious Diseases, 8(2), 101–107.https://doi.org/10.20473/ijtid.v8i2.2020.101-107

Rodriguez, MES, & Silveyra, P. (2021). Air pollution exposure as a relevant risk factor for COPD exacerbations in male and female patients. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1–10.https://doi.org/10.2147/COPD.S295982

Saklani, S., Bisht, S., & Joshi, Y. (2022). Assessment of demographic, etiologic and co-morbidity status among COPD patients. World Journal of Pharmaceutical Sciences, 10, 10–15.https://doi.org/10.54037/WJPS.2022.100702

Singh, D., Donohue, J.F., Boucot, I.H., Barnes, N.C., Compton, C., & Martinez, F.J. (2021). Future concepts in bronchodilation for COPD: Dual-versus monotherapy. European Respiratory Review, 30(160), 1–12.https://doi.org/10.1183/16000617.0192-2020

Sugiyono. (2021). Quantitative, qualitative, and R&D research methods (2nd ed.). Alfabeta.https://doi.org/10.31219/osf.io/8x3pn

Sudaryono. (2021). Research methodology: A practical research guide for students. Deepublish.https://doi.org/10.31219/osf.io/7gk9t

Tamondong-Lachica, D.R., Skolnik, N., Hurst, J.R., Marchetti, N., Rabe, APJ, de Oca, M.M., et al. (2023). GOLD 2023 update: Implications for clinical practice. International Journal of Chronic Obstructive Pulmonary Disease, 18(May), 745–754.https://doi.org/10.2147/COPD.S410123

Whittaker, H., Rubino, A., Müllerová, H., Morris, T., Varghese, P., & Xu, Y. (2022). Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: A UK routine health care data study. International Journal of Chronic Obstructive Pulmonary Disease, 17, 427–437.https://doi.org/10.2147/COPD.S346982